Scientists test custom cancer vaccine made from Patient's own tumor
NCT ID NCT01753089
Summary
This early-stage trial tested a personalized vaccine for people with advanced melanoma that had spread. Doctors made the vaccine by taking a sample of a patient's own tumor, processing it, and combining it with immune-stimulating proteins into a small, dissolvable tablet implanted under the skin. The main goals were to see if the vaccine could be made safely and if it could trigger the patient's immune system to attack their cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02215, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.